Augdahl Mark Richard
Known title: Interim CFOCIK: 0001520126
Augdahl Mark Richard's purchase track record
Augdahl Mark Richard has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 4/12/2023 | APOG | $56K | +17.6% | +13.1% | +7.0% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| APOG | ▼ Sell | Tax Withholding | 1,980 | $72K | 4/30/2026 | View on chart |
| APOG | ▲ Buy | Grant | 11,630 | $413K | 4/22/2026 | View on chart |
| APOG | ▲ Buy | Grant | 905 | $32K | 4/22/2026 | View on chart |
| APOG | ▼ Sell | Tax Withholding | 428 | $15K | 4/22/2026 | View on chart |
| APOG | ▲ Buy | Grant | 18,960 | $700K | 1/19/2026 | View on chart |
| APOG | ▲ Buy | Grant | 3,408 | $150K | 4/19/2023 | View on chart |
| APOG | ▲ Buy | Open Market | 1,334 | $56K | 4/12/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
Apogee Enterprises Completes GroGlass Acquisition
Apogee Enterprises has completed the acquisition of GroGlass, a move intended to expand its Performance Surfaces segment. This strategic addition aims to broaden the company's product offerings within that specific business unit. The stock is currently trading near its 52-week low, with an average analyst target price of $44.00.
Apogee Enterprises Completes GroGlass Acquisition. Apogee Enterprises has completed the acquisition of GroGlass, a move intended to expand its Performance Surfaces segment. This strategic addition aims to broaden the company's product offerings within that specific business unit. The stock is currently trading near its 52-week low, with an average analyst target price of $44.00.